Net Cash Provided by (Used in) Investing Activities in USD of SQZ Biotechnologies Co from 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
SQZ Biotechnologies Co quarterly/annual Net Cash Provided by (Used in) Investing Activities history and change rate from 2019 to Q1 2023.
  • SQZ Biotechnologies Co Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Mar 2023 was -$65K, a 66.5% increase year-over-year.
  • SQZ Biotechnologies Co annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$488K, a 20.4% increase from 2021.
  • SQZ Biotechnologies Co annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$613K, a 101% decline from 2020.
  • SQZ Biotechnologies Co annual Net Cash Provided by (Used in) Investing Activities for 2020 was $57.8M.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Change (%)

SQZ Biotechnologies Co Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$65K +$129K +66.5% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2023
Q1 2022 -$194K +$53K +21.5% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023
Q1 2021 -$247K -$30.9M -101% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022
Q1 2020 $30.7M 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021

SQZ Biotechnologies Co Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$488K +$125K +20.4% 01 Jan 2022 31 Dec 2022 10-K 22 Mar 2023
2021 -$613K -$58.4M -101% 01 Jan 2021 31 Dec 2021 10-K 22 Mar 2023
2020 $57.8M +$70.7M 01 Jan 2020 31 Dec 2020 10-K 16 Mar 2022
2019 -$12.8M 01 Jan 2019 31 Dec 2019 10-K 18 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.